Innovative Pharmaceutical Biotech (HKSE:00399) Future 3-5Y EPS without NRI Growth Rate : N/A (As of May. 23, 2025)

View and export this data going back to 2000. Start your Free Trial

What is Innovative Pharmaceutical Biotech Future 3-5Y EPS without NRI Growth Rate?

Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, Innovative Pharmaceutical Biotech's Future 3-5Y EPS without NRI Growth Rate is N/A.

Competitive Comparison of Innovative Pharmaceutical Biotech's Future 3-5Y EPS without NRI Growth Rate

For the Specialty Retail subindustry, Innovative Pharmaceutical Biotech's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Innovative Pharmaceutical Biotech's Future 3-5Y EPS without NRI Growth Rate Distribution in the Retail - Cyclical Industry

For the Retail - Cyclical industry and Consumer Cyclical sector, Innovative Pharmaceutical Biotech's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Innovative Pharmaceutical Biotech's Future 3-5Y EPS without NRI Growth Rate falls into.

Save Embed

;

Save Embed

;

Innovative Pharmaceutical Biotech (HKSE:00399) Future 3-5Y EPS without NRI Growth Rate Explanation

Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.

Innovative Pharmaceutical Biotech Future 3-5Y EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Innovative Pharmaceutical Biotech's Future 3-5Y EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Innovative Pharmaceutical Biotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Retail - Cyclical » Innovative Pharmaceutical Biotech Ltd (HKSE:00399) » Definitions » Future 3-5Y EPS without NRI Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

145 Hennessy Road, Unit No. 2002, 20th Floor, On Hong Commercial Building, Wan Chai, Hong Kong, HKG

Website

http://www.ipb.asia

Innovative Pharmaceutical Biotech Ltd is a Hong Kong-based investment holding company principally engaged in pharmaceuticals and biotechnology businesses. The company has two operating segments; Trading of beauty products in Hong Kong and Research, development, and commercialisation of the oral insulin product. The company generates almost all of its revenue from Hong Kong.

Executives

Chau Yiu Ting	2101 Beneficial owner
Mao Yumin	2101 Beneficial owner
Extrawell Pharmaceutical Holdings Limited
Mao Yumin	2101 Beneficial owner
Chau Yiu Ting	2101 Beneficial owner

Innovative Pharmaceutical Biotech Headlines

No Headlines